Q1 2025 Oncolytics Biotech Inc Earnings Call Transcript

Author's Avatar
May 15, 2025

May 14, 2025 / 08:30PM GMT
Operator

Good afternoon and welcome to Oncolytics Biotech's first-quarter conference call. (Operator Instructions) Please be advised that this call is being recorded at the company's request.

I would like to turn a call over to Jon Patton, Director of Investor Relations and Communication. Please go ahead.

Jon Patton - Oncolytics Biotech Inc - Director of Investor Relations and Communication

Thank you, operator. Today we'll provide an update on the quarter and a review of our financials. As a reminder, various remarks made during this call contain certain forward-looking statements relating to the company's business prospects and the development and commercialization of pelareorep, including statements regarding the company's ongoing CEO search, our mission, strategies, and milestones; the company's belief as to the potential and mechanism of action of pelareorep as a cancer therapeutic; our potential registrational opportunities for pelareorep and our plans and strategies related there too; our plans to continue enrollment in GOBLET Cohort 5; our ongoing

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot